- Dexcom ONE+ is available today in Spain, Belgium, and Poland
with the Netherlands launching next week, and additional countries
to be announced in the coming months.
- New system continues to ensure more people can gain access to
accurate1, easy-to-use†2, real-time CGM1.
- Dexcom ONE+ uses Dexcom’s best-in-class, most accurate, sensor
design and incorporates user and prescribing doctor feedback.
- People with Type 1 and Type 2 diabetes now have an easier way
to manage their condition and see their glucose readings, without
painful fingerpricks*.
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time
continuous glucose monitoring (CGM) for people with diabetes, today
announced the launch of their latest CGM system, Dexcom ONE+. The
system is available today in Spain, Belgium, and Poland and
launches next week in the Netherlands. In some countries Dexcom
ONE+ replaces the previous generation Dexcom ONE sensor. Dexcom
ONE+ uses Dexcom’s best-in-class and most accurate sensor design.
Dexcom also incorporated feedback from both end users and
healthcare professionals when building Dexcom ONE+, ensuring an
easy-to-use, highly effective, CGM experience for people treating
their Type 1 or Type 2 diabetes with insulin.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240205348202/en/
Dexcom ONE+ real-time Continuous Glucose
Monitoring (rt-CGM) System (Photo: Business Wire)
“Dexcom ONE+ incorporates our best-in-class technology and a
range of features that we know will be well-received by the
diabetes community,” said Teri Lawver, Executive Vice President and
Chief Commercial Officer at Dexcom. “By building Dexcom ONE+ based
on user and healthcare professional feedback we know we have a CGM
system that is flexible, easy to get started with, and intuitive to
use; a system that people with either Type 1 or Type 2 diabetes,
and their care teams, can benefit from.”
“In my conversations with Dexcom, I expressed the importance of
CGM being easy to use for people with diabetes and their care
teams,” said Dr. Liesbeth van Huffel. “Dexcom ONE+ is now an
all-in-one sensor, very easy to apply and use. This makes diabetes
technology more accessible as it lowers the barrier to getting
started.
“Another important element was adding notes at certain moments,
such as meals, insulin administration or sports activities.
Compared to finger sticks, a CGM sensor provides a much clearer
picture of how daily choices affect glucose levels. Dexcom sensors
are known for their accuracy and reliability and now adding this
note option to Dexcom ONE+ makes it even more transparent for the
care team when coaching someone.”
For people managing diabetes using fingerpricks and regularly
injecting insulin, their lives can feel overwhelmed by diabetes.
Dexcom ONE+ was developed to take away some of this burden, it’s
easy to get started with** and is designed to be easy to live with,
even for those with no experience of using a CGM system. Like all
Dexcom CGM, Dexcom ONE+ gives a clear picture of what glucose
levels are doing in real-time, without painful fingerpricks*,
therefore making it easier‖ for people to achieve lasting results§
3, ‡‡,5 ,6. Importantly, for loved ones, Dexcom ONE+ also allows a
user to easily share their glucose numbers with up to ten people,
offering everyone a little more peace of mind††.
“Dexcom ONE+ continues the work of Dexcom ONE in bringing access
to our life-changing technology to millions of people across
Europe, the Middle East and Africa,” said Alex Moussa, Senior Vice
President and General Manager for Dexcom EMEA & LATAM. “Through
our ongoing innovation and product development, not only are we
bringing the best, and most accurate, version of our technology to
even more people, but we continue to show our commitment to
significantly expanding access to CGM for people with all types of
diabetes.”
Features that set Dexcom ONE+ apart from other CGM systems
include multiple possibilities for personalisation and flexibility.
Dexcom CGM systems offer the most discretion, with three wear
location options‡ 1,4 and are the only CGM systems to offer a
‘delay first high’ option1, a customisable feature which allows a
user to set a time before which their sensor will not alert them to
a ‘high’ glucose reading, helping to avoid alert fatigue.
Furthermore, designed to fit seamlessly into a user’s life, Dexcom
ONE+ also has the highest waterproof rating when compared to other
CGM brands, allowing users to confidently continue using their
device while showering or exercising.
Dexcom ONE+ is available today in Spain, Belgium and Poland, and
will be available in the Netherlands next week. Additional
countries in Europe, the Middle East and Africa will be announced
in the following months.
To find out more information about how Dexcom ONE+ can benefit
you or your loved one speak to your doctor or visit dexcom.com
Category: IR
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, Calif., and with operations across
Europe, Dexcom has emerged as a leader of diabetes care technology.
By listening to the needs of users, caregivers, and providers,
Dexcom works to simplify and improve diabetes management around the
world. For more information about Dexcom CGM, visit
www.dexcom.com.
† Results obtained with Dexcom G7 study, which shares the
similar features and usability
* If the glucose alerts and readings do not match symptoms a
blood glucose meter should be used to make diabetes treatment
decisions.
** Compared to previous generation Dexcom CGM System, Dexcom
ONE
‖ Compared to Blood Glucose Meter patient use
§ Previous generation Dexcom CGM used, Dexcom ONE+ uses the same
sensor as G7
‡‡ Study included non-Dexcom CGM system
‡ Dexcom ONE+ is approved for wear on the arm and abdomen, and
children 2-6 years can also wear their sensor on the upper
buttocks
The Dexcom ONE+ Sensor is waterproof and may be submerged under
2.4 Meters of water for up to 24 hours without failure when
properly installed.
†† Separate Follow app and internet connection required
1 Dexcom ONE+ User Guide, 2023. 2. Dexcom Data on file 2022. 3
Lind M, et al. Diabetes Care. 2021;44(1):141-149. 4. Freestyle
Libre 2, Medtronic and Senseonics User Guides. 5 Soupal J, et al.
Diabetes Care. 2020; 43: 37-43. 6 Welsh JB, et al. J Diabetes Sci
Technol. 2024;18(1):143-147
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240205348202/en/
Gemma McDonald, Dexcom: gemma.mcdonald@dexcom.com Allison for
Dexcom, DexcomEMEA@allisonworldwide.com
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024